OHRP another pharma that had a drug fail to meet its end point. It will be dead for about a year until they get another drug to "test". The run up was in anticipation of the drug being successful. But only 13% of new drugs are approved by the FDA. Holding until the results of any drug is a very low odds game.
The way to play these little pharma's is to get in as a new study gets underway and to get out before the results.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.